According to researchers, the adapted treatment could help to prevent muscle damage and permanent physical impacts.

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

A new study shows mRNA-based treatment can protect muscle tissue from snake venom damage, offering a potential boost to ...

The success of mRNA technology and its potential uses in therapeutics and preventative medical treatment may create a new technology ecosystem, the Harvard Business Review reported April 18. As has ...

Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional proteins in the body and induces therapeutic effects.

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and ...

Mycobacterium tuberculosis (Public Health Image Library, NIAID, Image ID: 18139) Mycobacterium tuberculosis (Public Health Image Library, NIAID, Image ID: 18139) Tuberculosis (TB) is the number one ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. JR Whalen: Here's your mid-day brief for Friday, July 23rd. I'm J.R. Whalen for ...

The United States market has recently seen a mix of gains and declines, with the Dow Jones Industrial Average and S&P 500 ...